$FATE
Fate Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$2.13
▼-0.93%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateFate Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is FATE down today? It is at $2.13 (-0.93%), and our scanner flagged it 65 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment FATE spikes, and full due diligence on FATE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $FATE 65 times in the last 30 days. Create a free account to track $FATE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on FATE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FATE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Valamehr Bahram Officer | Sold (automatic/other) | -44K 0.04% of company | sold 6.9% | 592K | $108K at $2.46 | Aug 4, 26 |
Tahl Cindy Officer | Sold (automatic/other) | -39K 0.03% of company | sold 6.2% | 589K | $95K at $2.46 | Aug 4, 26 |
Valamehr Bahram Officer | Sold (automatic/other) | -29K 0.02% of company | sold 4.4% | 636K | $54K at $1.88 | May 20, 26 |
Tahl Cindy Officer | Sold (automatic/other) | -26K 0.02% of company | sold 3.9% | 628K | $48K at $1.88 | May 20, 26 |
Tahl Cindy Officer | Other | 167K 0.1% of company | added 34% | 654K | $175K at $1.05 | May 6, 26 |
Rastetter William H Director | Other | 25K 0.02% of company | added 100% | 36K | $42K at $1.69 | May 5, 26 |
Epstein Robert S Director | Other | 25K 0.02% of company | added 100% | 36K | $42K at $1.69 | May 5, 26 |
Redmile Group, Llc Director | Sold (automatic/other) | -8.98M 7.5% of company | n/a | n/a | n/a | Apr 20, 26 |
Redmile Group, Llc Director | Acquired (grant/award) | +8.98M 7.5% of company | added 100% | 12.88M | n/a | Apr 20, 26 |
Valamehr Bahram Officer | Acquired (grant/award) | +335K 0.3% of company | added 100% | 665K | n/a | Jan 15, 26 |
Adawi Kamal Officer | Acquired (grant/award) | +25K 0.02% of company | added 33% | 100K | n/a | Jan 15, 26 |
Tahl Cindy Officer | Acquired (grant/award) | +100K 0.08% of company | added 26% | 487K | n/a | Jan 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on FATE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FATE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
FATE last traded at $2.13, down 0.93% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Fate Therapeutics, Inc. (FATE) is next expected to report earnings on Thursday, November 12, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The FATE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged FATE 65 times in the last 30 days.
FATE (Fate Therapeutics, Inc.) trades on XNAS, with a market cap of about $255M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge FATE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$FATE discussion
Sign in to ask a question or join the discussion.